Within the second half of 2024, researchers will search authorization to start scientific trials with the novel antibody-drug conjugate.The Meals and Drug Administration...
We spoke with three myeloma specialists about myeloma-related questions sufferers ought to ask their medical doctors after a prognosis. The remedy panorama for...